Suprascapular nerve peripheral nerve stimulation for pediatric cancer pain: a case series.

ABSTRACT

Aim: Despite the growing evidence supporting the use of peripheral nerve stimulation (PNS) for cancer pain in adults, it is underutilized in the pediatric oncology population.Method: We describe the use of temporary, percutaneous PNS for pain management in pediatric patients suffering from cancer related pain.Results: Two adolescent patients underwent an ultrasound-guided suprascapular nerve PNS placement utilizing the percutaneous 60-day therapy system. Both patients reported approximately 60% pain relief during the therapy, as well as up to 90 days post lead removal.Conclusion: PNS may play a crucial role in the pediatric oncology population. Further studies are warranted to investigate the efficacy and safety of PNS for various cancer-related pain conditions in pediatric populations.

Peripheral nerve stimulator is a device that uses electrical impulses to stimulate the nerves that send pain signals to the brains. This device may be useful in treating pain in cancer patients. We highlight two pediatric cancer patients that had pain relief using a specific type of peripheral nerve stimulator that is removed after 60 days. It is thought that pain relief is sustained even after removing the stimulator by altering the pain signals to the brain. This treatment may serve an important role in treating pediatric cancer pain.